Key result
Current risk stratification for sudden cardiac death after myocardial infarction relies heavily on left ventricular ejection fraction, but multivariable models and novel tests may improve patient selection for implantable cardioverter-defibrillators.
Answers are grounded in this paper and cite their sources.
Relying solely on LVEF for post-MI sudden cardiac death risk stratification is inadequate, and incorporating additional electrophysiological tests may improve patient selection for ICD implantation.
Despite advances in the diagnosis and treatment of acute coronary syndromes and an overall improvement in outcomes, mortality after myocardial infarction (MI) remains high. Sudden death, which is most frequently due to ventricular tachycardia or ventricular fibrillation, is the cause of death in 25% to 50% of patients with prior MI, and therefore represents an important public health problem. Use of the implantable cardioverter-defibrillator (ICD), which is the primary method of reducing the chance of arrhythmic sudden death after MI, is costly to the medical system and is associated with procedural and long-term risks. Additionally, assessment of left ventricular ejection fraction (LVEF), which is the primary method of assessing a patient's post-MI sudden death risk and appropriateness for ICD implantation, lacks both sensitivity and specificity for sudden death, and may not be the optimal way to select the subgroup of post-MI patients who are most likely to benefit from ICD implantation. To optimally utilize ICDs, it is therefore critical to develop and prospectively validate sudden death risk stratification methods beyond measuring LVEF. A variety of tests that assess left ventricular systolic function/morphology, potential triggers for ventricular arrhythmias, ventricular conduction/repolarization, and autonomic tone have been proposed as sudden death risk stratification tools. Multivariable models have also been developed to assess the competing risks of arrhythmic and non-arrhythmic death so that ICDs can be utilized more effectively. This manuscript will review the epidemiology of sudden death after MI, and will discuss the current state of sudden death risk stratification in this population.
No takes yet. Share an insight, caveat, or question.
Bui et al. (2018) conducted a review in Sudden Cardiac Death After Acute Myocardial Infarction. Risk stratification methods was evaluated. Current risk stratification for sudden cardiac death after myocardial infarction relies heavily on left ventricular ejection fraction, but multivariable models and novel tests may improve patient selection for implantable cardioverter-defibrillators.
Synapse has enriched 10 related papers. Consider them for comparative context: